Aflac (AFL) stock: key figures, P/E, revenue and dividend

Financials · Life & Health Insurance · United States · ISIN US0010551028

Price
118.21 USD
Market cap
59.26 bn USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
2.04 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Aflac financials

Fiscal year2025
Revenue17.16 bn USD
EBIT4.75 bn USD
Net income3.65 bn USD
Diluted EPS – continuing operations6.82 USD

Full history since 1985, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.

Aflac stock (AFL): P/E, revenue, dividend | finmetric